- Filed
- Nov 15, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Nov 10, 2021 | 127.74M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 127.17M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 109.99M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 8.89M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 8.88M sh |
| Capex | Q3 2021 · Sep 30, 2021 | $5.22M |
| Capex | Q3 2021 · Sep 30, 2020 | $6.27M |
| Operating Cash Flow | Q3 2021 · Sep 30, 2021 | −$70.33M |
| Operating Cash Flow restated | Q3 2021 · Sep 30, 2020 | −$19.34M |
| Long Term Debt | Q3 2021 · Sep 30, 2021 | $0 |
| Long Term Debt | Q3 2021 · Dec 31, 2020 | $51.93M |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $159.16M |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $19.15M |
| Stockholders Equity | Q3 2021 · Sep 30, 2021 | $217.06M |
| Stockholders Equity | Q3 2021 · Jun 30, 2021 | $235.52M |
| Stockholders Equity | Q3 2021 · Dec 31, 2020 | −$361.5M |
| Stockholders Equity restated | Q3 2021 · Sep 30, 2020 | −$278.42M |
| Stockholders Equity restated | Q3 2021 · Jun 30, 2020 | −$268.17M |
| Stockholders Equity restated | Q3 2021 · Dec 31, 2019 | −$243.01M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $114.99M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $259.19M |
| Total Assets | Q3 2021 · Sep 30, 2021 | $332.04M |
| Total Assets | Q3 2021 · Dec 31, 2020 | $202.16M |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | −$0.21 |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | −$1.56 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$1.20 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$4.10 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | −$0.21 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | −$1.56 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$1.20 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$4.10 |
| Rd Expense | Q3 2021 · Sep 30, 2021 | $5.13M |
| Rd Expense | Q3 2021 · Sep 30, 2021 | $11.9M |
| Rd Expense | Q3 2021 · Sep 30, 2020 | $1.83M |
| Rd Expense | Q3 2021 · Sep 30, 2020 | $6.67M |
| Net Income | Q3 2021 · Sep 30, 2021 | −$26.76M |
| Net Income | Q3 2021 · Sep 30, 2021 | −$171.64M |
| Net Income restated | Q3 2021 · Sep 30, 2020 | −$10.63M |
| Net Income restated | Q3 2021 · Sep 30, 2020 | −$36.42M |
| Operating Income | Q3 2021 · Sep 30, 2021 | −$37.66M |
| Operating Income | Q3 2021 · Sep 30, 2021 | −$147.35M |
| Operating Income restated | Q3 2021 · Sep 30, 2020 | −$9.21M |
| Operating Income restated | Q3 2021 · Sep 30, 2020 | −$32.39M |
| Revenue | Q3 2021 · Sep 30, 2021 | $30M |
| Revenue | Q3 2021 · Sep 30, 2021 | $75.38M |
| Revenue | Q3 2021 · Sep 30, 2020 | $7.95M |
| Revenue | Q3 2021 · Sep 30, 2020 | $24.36M |